Want more time with less lines?  DAXXIFY is the only long-lasting, peptide-powered frown line treatment.  Make a date with DAXXIFY and you’ll be wrinkle-free until Summer 2023!

After a two-year wait, AUSTEX Wellness is proud to announce that we are now offering DAXXIFY.   DAXXIFY is the first and only peptide–powered, FDA-approved frown line treatment with a median duration of 6 months, and up to 9 months for some patients. Clinical studies reported an onset of 1-2 days for the treatment to take affect.  Because of our long-standing partnership with Revance, we’re one of the first practices to start treating patients now.

DAXXIFY is the only long-lasting, peptide-powered frown line treatment and the first innovation of its kind in over 20 years.   While DAXXIFY lasts 2 to 3 times longer than Dysport or Botox, it will not cost 2-3 times more.

BOOK AN APPOINTMENT!

Call or text us at 512-524-9602 to book a 15-minute consult, or a 30-minute treatment appointment with Nurse Practitioner Lisa.  She’s booking appointments Monday through Friday from 10 am to 6 pm.

USE CHERRY FINANCING!

Treat yourself now to DAXXIFY now and pay later with Cherry Financing! Get pre-approved before your next appointment.

Learn More

FREQUENTLY ASKED QUESTIONS ABOUT DAXXIFY

Q: What is DAXXIFY and what can it treat?

A:  DAXXIFY is the first and only peptide–powered, FDA-approved frown line treatment with a median duration of 6 months, and up to 9 months for some patients. DAXXIFY has a 1-2 day onset.  We’ve been waiting for two years for FDA approval.  DAXXIFY is the first and only neuromodulator to be manufactured and launched in the US.

Q:  How long does it last? When does it kick in?

A:  DAXXIFY is an FDA-approved frown line treatment with a median duration of 6 months, and up to 9 months for some patients. DAXXIFY has a 1-2 day onset. 9 out of 10 neuromodulator patients reported wanting a longer lasting treatment, DAXXIFY meets that need. Some patients maintained treatment results at 9 months.

Q: How safe is DAXXIFY?

A:   The U.S. approval of DAXXIFY™ was based on the data generated in the SAKURA Phase 3 clinical trial program SAKURA which included more than 2,700 patients and approximately 4,200 treatments.  DAXXIFY is generally safe and well tolerated with no serious treatment-related adverse events reported in the clinical trials and has a safety profile consistent with other currently available neuromodulators in the aesthetics market.  Based on the data from the SAKURA clinical trials, DAXXIFY has the ability to deliver year-long results in as few as two treatments per year, and has been proven to be effective, generally safe, and well tolerated.

Q:  How is DAXXIFY different from Botox or Dysport?

A:  DAXXIFY is a whole new category of neuromodulator, as the first- and only-peptide powered neuromodulator FDA-approved for frown line treatment with a duration of 6 months.  Our practice will continue to treat with Botox and Dysport as we have done for years. DAXXIFY is just another option for patients who seek a longer duration wrinkle reducer. The DAXXIFY Peptide replaces the Human Serum Albumin found in all other Neuromodulators. Because of this, DAXXIFY is the only vegan neuromodulator available. DAXXIFY is the first and only neuromodulator to be manufactured and launched in the US. DAXXIFY is approved to last two to three times longer than Botox or Dysport, but it is not two to three times more expensive.

Q:  Is DAXXIFY vegan?

A: Yes, the DAXXIFY Peptide replaces the Human Serum Albumin found in all other Neuromodulators. Because of this, DAXXIFY is the only vegan neuromodulator available on the market.

Q:  How is DAXXIFY priced?

A:  Each patient is unique in their needs.  The best step is to book a consultation with our Nurse Practitioner Lisa. She will develop a care plan and pricing to meet your goals. Treat now, and pay later with Cherry Financing at 0% interest for 3, 6, or 12 months.

Q:  Who injects DAXXIFY at AUSTEX Wellness?

A:  Our Nurse Practitioner Lisa has been practicing for more than 20 years, and has injected thousands of patients for all of the available neuromodulators.  As an Elite Nurse Practitioner, Lisa and AUSTEX Wellness have built a strong relationship with Revance Aesthetics as a preferred partner to launch DAXXIFY.

Q: Who manufactures DAXXIFY?

A:  Revance is a commercial stage biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences. Revance’s aesthetics portfolio of expertly created products and services, including DAXXIFY and the RHA Collection of dermal fillers. Learn more at www.Revanceaesthetics.com.

Q:  Who is not a good candidate for DAXXIFY?

A:  Pregnant or nursing mothers are not good candidates for treatment with DAXXIFY.

Q:  How is DAXXIFY™ different from facial fillers, also known as dermal fillers?

A:  DAXXIFY™ minimizes the appearance of moderate to severe frown lines by temporarily relaxing the underlying muscles that cause these wrinkles. DAXXIFY™ is a long-lasting botulinum toxin type A treatment with a novel peptide.

Facial fillers, also known as dermal fillers, are typically made of hyaluronic acid and are used to add volume, fullness, and structure to areas of the face. They can help contour cheekbones, soften lines around the nose and mouth, and volumize lips. Dermal fillers target volume loss rather than muscle-related wrinkles.